Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists. Pryce G, Visintin C, Ramagopalan SV, Al-Izki S, De Faveri LE, Nuamah RA, Mein CA, Montpetit A, Hardcastle AJ, Kooij G, et al. FASEB J. 2013 Oct 22. Epub 2013 Oct 11. PMID: 24121462. Abstract CommentRecommendBookmarkWatch